Results 101 to 110 of about 142,415 (276)

Molecular imaging predicts trastuzumab‐deruxtecan (T‐DXd) response in head and neck cancer xenograft models

open access: yesMolecular Oncology, EarlyView.
Trastuzumab‐deruxtecan, a HER2‐targeting antibody‐drug conjugate, shows promising antitumor activity in head and neck squamous cell carcinoma with low HER2 expression. In vitro and in vivo studies demonstrated dose‐dependent cell death and tumor growth reduction in low HER2‐expressing cell lines, which correlated with drug accumulation measured using a
Abdullah Bin Naveed   +8 more
wiley   +1 more source

Stability and boundedness of solutions of the initial value problem for a class of time-fractional diffusion equations

open access: yesAdvances in Difference Equations, 2017
The aim of this paper is to study the stability and boundedness of solutions of the initial value problem for a class of time-fractional diffusion equations.
Yanhua Wen, Xian-Feng Zhou, Jun Wang
doaj   +1 more source

On Rado's Boundedness Conjecture

open access: yesJournal of Combinatorial Theory, Series A, 2006
AbstractWe prove that Rado's Boundedness Conjecture from Richard Rado's 1933 famous dissertation Studien zur Kombinatorik is true if it is true for homogeneous equations. We then prove the first nontrivial case of Rado's Boundedness Conjecture: if a1, a2, and a3 are integers, and if for every 24-coloring of the positive integers (or even the nonzero ...
Daniel J. Kleitman, Jacob Fox
openaire   +2 more sources

The subcellular distribution of phosphorylated Y‐box‐binding protein‐1 at S102 in colorectal cancer patients, stratified by KRAS mutational status and clinicopathological features

open access: yesMolecular Oncology, EarlyView.
This study identifies nuclear YB‐1 S102 phosphorylation as a marker associated with KRAS and FBXW7 mutations in colorectal cancer. Mutated KRAS correlates specifically with nuclear, not cytoplasmic, S102 YB‐1. These findings provide the first ex vivo evidence of this link in CRC and suggest future studies should assess the prognostic and therapeutic ...
Konstanze Lettau   +9 more
wiley   +1 more source

Mathematical study of polycystic ovarian syndrome disease including medication treatment mechanism for infertility in women

open access: yesAIMS Public Health
Among women of reproductive age, PCOS (polycystic ovarian syndrome) is one of the most prevalent endocrine illnesses. In addition to decreasing female fertility, this condition raises the risk of cardiovascular disease, diabetes, dyslipidemia, obesity ...
Maryam Batool   +3 more
doaj   +1 more source

Weighted composition operators acting from the Lipschitz space to the space of bounded functions on a tree

open access: yes, 2019
We study the weighted composition operators between the Lipschitz space and the space of bounded functions on the set of vertices of an infinite tree.
Hosokawa, Takuya
core  

A nucleotide‐independent, pan‐RAS‐targeted DARPin elicits anti‐tumor activity in a multimodal manner

open access: yesMolecular Oncology, EarlyView.
We report a Designed Ankyrin Repeat Protein that binds and inhibits RAS proteins, which serve as central cell signaling hubs and are essential for the progression of many cancers. Its unique feature is that it does not discriminate between different RAS isoforms or mutations and is capable of binding to RAS in both its active (GTP‐bound) and inactive ...
Jonas N. Kapp   +13 more
wiley   +1 more source

Global behavior of a discrete population model

open access: yesAIMS Mathematics
In this work, the global behavior of a discrete population model $ \begin{equation*} \begin{cases} x_{n+1}& = \alpha x_n e^{-y_n}+\beta,\\ y_{n+1}& = \alpha x_n(1-e^{-y_n}), \end{cases}\quad n = 0,1,2,\dots, \end{equation*} $ is considered,
Linxia Hu, Yonghong Shen, Xiumei Jia
doaj   +1 more source

Simultaneous inhibition of TRIM24 and TRIM28 sensitises prostate cancer cells to antiandrogen therapy, decreasing VEGF signalling and angiogenesis

open access: yesMolecular Oncology, EarlyView.
TRIM24 and TRIM28 are androgen receptor (AR) coregulators which exhibit increased expression with cancer progression. Both TRIM24 and TRIM28 combine to influence the response of castrate‐resistant prostate cancer (CRPC) cells to AR inhibitors by mediating AR signalling, regulation of MYC and upregulating VEGF to promote angiogenesis. Castrate‐resistant
Damien A. Leach   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy